SADDLE BROOK, N.J.,
Dec. 7, 2011 /PRNewswire/ --
Herborium Group, Inc., (PK: HBRM) is pleased to announce that its
recently launched social media marketing campaign for its acne
treatment, AcnEase®, is already producing positive results.
Cyber Monday sales for AcnEase, the Company's flagship all
botanical acne treatment, grew 27% as compared to 2010. The Company
contributes this growth to the efforts being employed in the social
media space to bring AcnEase to the consumers worldwide. Initial
activities have included an updated FaceBook and Twitter presence,
a new blog and third party representations in the beauty
industry.
"We believe that this most satisfying increase in sales of
AcnEase is just the beginning of the impact our strategies will
have on sales. The extremely positive consumer response to the
initial phase of our social media strategy is a strong indicator of
future growth in revenues," commented Dr. Agnes P. Olszewski, President and CEO of
Herborium.
"AcnEase is an all botanical ingredients based product that has
proven effective for eliminating acne in both teenagers and adults
of all ethnic groups with consumers with all skin types and colors
benefiting from the results. AcnEase is safe and effective
and can be used by both women and men without irritating,
bleaching or discoloring the skin. As a result of this broad
beneficial characteristics of AcnEase, Herborium has undertaken a
number of initiatives to reach different –so far untapped ethnic
markets of acne sufferers in the US and Europe. Our focus ending 2011 and going into
2012 will be on bringing those initiatives to fruition in terms of
revenues," concluded Dr. Olszewski
About The $50 Billion Acne
Market
Over 130 million individuals of all ethnic backgrounds are
currently diagnosed with Acne in the USA and Europe alone with the $50 billion in revenues generated in acne
treatments worldwide. For the past decade there is a steady
growth in a total number of individuals suffering from acne and in
sales acne treatments. New market needs are also emerging in
this sector. Three most important of those trends became a special
focus of Herborium marketing strategy: Increase in incidents
of Adult Acne (over 17 million adults in the USA have acne) while most of acne treatments
focus on teenagers; a growing demand for acne treatment suitable
for all ethnic groups (while the supply of efficacious, targeted
products in this category is almost non-existent); and the demand
for truly natural and treatment that can provide satisfactory
results.
About AcnEase (www.acnease.com)
AcnEase® is a proprietary, all herbal, systemically acting
botanical therapeutic® targeting the symptoms of acne in both
females and males of all ages. Unlike many herbal products, AcnEase
has been validated through clinical testing. The results
demonstrated that approximately 95% of the patients with adolescent
acne responded positively to AcnEase. In adults with hormonal or
chronic acne the level of effectiveness was 85%. The overall
positive response rate to AcnEase was 91%. To date, after 5 plus
years on the market, Herborium has registered a 95.5% consumer
satisfaction rate for the AcnEase product.
About Herborium Group, Inc. (www.herborium.com)
Herborium Group, Inc., a botanical therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company business model focuses on emerging
market opportunities spearheaded by the growth of a new market
sector located between high-cost, high-risk, ethical
pharmaceuticals and commoditized classic nutraceuticals
(supplements). The Company uses clinical validation and a
proactive regulatory strategy based on the FDA Guidance for
Industry: Botanical Drug Products (FDA Guidance 2004) to establish
and maintain a differential advantage. The company secured a
pipeline of botanical ingredients based products in the areas of
Dermatology, Prostate Health (BPH), Liver Diseases and Women's and
Men's Health and selected sexual disorders. Herborium Group sells
its products in the United States,
the United Kingdom, and
continental Europe through a
network of distributors, specialty retailers, and e-commerce.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are
based on current management expectations, and are
considered "forward-looking statements," generally
preceded by words such as "plans," "expects," "believes,"
"anticipates," or "intends." We cannot promise
future returns. Our statements reflect our best
judgment at the time, and we disclaim any obligation to update or
alter forward-looking statements as the result of new information
or future events. The Company urges investors
to review the risks and uncertainties contained within its filings
with the OTC Markets and/or Securities and Exchange
Commission
For more information please inquire:
DrAgnes@Herborium.com
SOURCE Herborium Group, Inc.
